The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Automated Drug Compounding Systems Market During 2026–2030?

The automated drug compounding systems market size has experienced swift growth in recent years. It is anticipated to expand from $1.85 billion in 2025 to $2.08 billion in 2026, at a compound annual growth rate (CAGR) of 12.3%. The historical expansion of this market can be attributed to several factors, including the increasing adoption of automated systems in hospital pharmacies, a rising need to minimize medication errors, a growing focus on sterile and accurate drug preparation, the increasing workflow burden on pharmacy staff, and a rising demand for time-saving compounding processes.

The automated drug compounding systems market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $3.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.0%. Several factors are expected to drive this growth during the forecast period, including increased investment in healthcare automation, greater adoption of software and automation tools, the expanding requirement for standardization in drug compounding, a heightened emphasis on minimizing contamination risks, increased hospital expenditure on automation infrastructure, and the growing demand for improved operational efficiency within pharmacies. Key trends foreseen in this period encompass advancements in robotic-assisted drug compounding technologies, breakthroughs in software integration for pharmacy management, the incorporation of AI to reduce errors in compounding, enhancements in real-time monitoring and quality control systems, and innovations in automated sterile compounding methods.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30527&type=smp

What Are The Main Drivers Accelerating The Growth Of The Automated Drug Compounding Systems Market?

The rising occurrence of chronic illnesses is anticipated to boost the expansion of the automated drug compounding systems market moving ahead. These conditions are persistent health issues, like diabetes, cardiac disease, and joint inflammation, which typically develop gradually and necessitate continuous medical care and lifestyle adjustments to manage symptoms and avert adverse effects. Their rise is primarily linked to unhealthy habits such as inadequate nutrition, lack of exercise, and tobacco use, elevating the likelihood of developing conditions like diabetes, heart disease, and obesity. Automated drug compounding systems assist in handling chronic diseases by accurately preparing personalized medications specific to each patient’s requirements. These systems boost the precision and uniformity of treatment, thereby minimizing mistakes and improving long-term health results. For example, in June 2024, data from the National Health Service, a UK government body, revealed that 3,615,330 individuals registered with a general practitioner (GP) had a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, showing an 18% rise from 3,065,825 instances in 2022. Consequently, the growing incidence of chronic diseases is propelling the expansion of the automated drug compounding systems market.

How Is The Automated Drug Compounding Systems Market Structured Across Different Market Segments?

The automated drug compounding systems market covered in this report is segmented –

1) By Product: Robotic Compounding Systems, Automated Liquid Compounding Systems, Tablet And Capsule Dispensers, Injectable Compounding Robots, IV Admixture Systems, Oral Liquid Compounding Systems

2) By Component: Equipment, Software, Consumables, Services

3) By Technology: Robotic-Based Systems, Semi-Automated Systems, Gravimetric Dosing Systems, Volumetric Dosing Systems, Hybrid Dosing Systems

4) By End-User: Hospitals, Clinics, Retail Pharmacies, Compounding Pharmacies, Pharmaceutical Manufacturers

Subsegments:

1) By Robotic Compounding Systems: Fully Automated Sterile Compounding Robots, Hazardous Drug Compounding Robots, Non-Hazardous Drug Compounding Robots, High-Throughput Pharmacy Robots, Closed-System Robotic Compounding Units

2) By Automated Liquid Compounding Systems: Large-Volume Parenteral (LVP) Compounding Systems, Small-Volume Parenteral (SVP) Compounding Systems, Multi-Drug Liquid Compounding Units, Volumetric And Gravimetric Liquid Compounding Systems, Pediatric Liquid Dosing Compounding Systems

3) By Tablet and Capsule Dispensers: Automated Tablet Counting Dispensers, Unit-Dose Packaging Systems, Multi-Dose Blister Dispensing Units, Capsule Filling and Dispensing Systems, High-Speed Pharmacy Dispensing Robots

4) By Injectable Compounding Robots: Chemotherapy Drug Compounding Robots, TPN (Total Parenteral Nutrition) Compounding Robots, High-Precision Syringe Preparation Robots, Sterile Injectable Filling Robots, Hazardous Injectable Handling Systems

5) By IV Admixture Systems: Automated IV Bag Filling Systems, IV Nutrition (TPN) Admixture Systems, IV Antibiotic Admixture Devices, Pharmacy Cleanroom IV Automation Units, Closed-System IV Compounding Systems

6) By Oral Liquid Compounding Systems: Pediatric Oral Liquid Compounding Machines, Flavoring & Suspension Mixing Systems, Multi-Ingredient Oral Liquid Compounding Units, Gravimetric Oral Solution Compounding Systems, Low-Volume Oral Dosing Compounding Systems

What Trends Are Impacting The Automated Drug Compounding Systems Market?

Major companies operating within the automated drug compounding systems market are concentrating on the creation of advanced systems, including total parenteral nutrition (TPN) automation systems, to improve the accuracy, safety, and efficiency involved in preparing individualized intravenous formulations. A total parenteral nutrition (TPN) automation system is defined as a compounding platform that both automates the mixing and dispensing of total parenteral nutrition (TPN) solutions and integrates prescription validation and workflow management tools, aiming to reduce human error and ensure sterile, high-quality preparation. For example, in May 2025, MediServ Co. Ltd. unveiled the APEX TPN Compounding System in Riyadh, initiating a new period of precision and automation for parenteral nutrition workflows. This system, featuring its EasyComp integration software, enhances the total parenteral nutrition (TPN) process by linking validated prescriptions directly to sterile, accurate compounding, thereby streamlining pharmacy operations and minimizing manual tasks.

Which Industry Players Are Present In The Automated Drug Compounding Systems Market?

Major companies operating in the automated drug compounding systems market are Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical Inc., Omnicell Inc., Eckert & Ziegler SE, Swisslog Healthcare AG, EQUASHIELD Medical Ltd., Trasis S.A., Loccioni Group S.p.A., ARxIUM Inc., Comecer S.p.A., Tema Sinergie S.p.A., Epic Medical Pte. Ltd., IBA Radiopharma Solutions S.A., Steriline S.r.l., Elysia-Raytest GmbH, Curifylabs OY, Kapsam Health Solutions Pvt. Ltd.

Access The Complete Automated Drug Compounding Systems Market Report:

https://www.thebusinessresearchcompany.com/report/automated-drug-compounding-systems-market-report

Which Region Is The Dominant Market In The Automated Drug Compounding Systems Market?

North America was the largest region in the automated drug compounding Systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated drug compounding systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Automated Drug Compounding Systems Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=30527&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model